BioMarin Pharmaceutical
BMRN
#1728
Rank
โ‚น1.109 T
Marketcap
โ‚น5,729
Share price
-0.02%
Change (1 day)
23.19%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2026 (TTM): โ‚น3.94 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are โ‚น3.65 Billion. In 2025 the company made an earning of โ‚น45.00 Billion a decrease over its 2024 earnings that were of โ‚น50.53 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น3.94 B-91.23%
2025 โ‚น45.00 B-10.94%
2024 โ‚น50.53 B187.31%
2023 โ‚น17.58 B26.07%
2022 โ‚น13.95 B-298.51%
2021 -โ‚น7.03 Billion78.04%
2020 -โ‚น3.95 Billion-55.36%
2019 -โ‚น8.85 Billion-33.56%
2018 -โ‚น13.32 Billion297.78%
2017 -โ‚น3.35 Billion-95.68%
2016 -โ‚น77.53 Billion437.12%
2015 -โ‚น14.44 Billion23.91%
2014 -โ‚น11.65 Billion-29.25%
2013 -โ‚น16.47 Billion49.23%
2012 -โ‚น11.04 Billion171.11%
2011 -โ‚น4.07 Billion103.01%
2010 -โ‚น2.01 Billion-3903.54%
2009 โ‚น52.7 M-98.31%
2008 โ‚น3.11 B-189.7%
2007 -โ‚น3.48 Billion51.02%
2006 -โ‚น2.31 Billion-61.58%
2005 -โ‚น5.99 Billion-56.59%
2004 -โ‚น13.8 Billion95.13%
2003 -โ‚น7.08 Billion12.09%
2002 -โ‚น6.31 Billion73.19%
2001 -โ‚น3.65 Billion18.32%
2000 -โ‚น3.08 Billion19.65%
1999 -โ‚น2.58 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚น726.46 B 17,735.86%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น41.72 Billion-1,124.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น10.3 Billion-352.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น7.40 B 81.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น17.81 M-99.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น27.65 B 578.94%๐Ÿ‡บ๐Ÿ‡ธ USA